Physician profile
Eric Lederman
NPI 1255368973
$10,911.07
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,378 · 2020: $839 · 2021: $1,097 · 2022: $122 · 2023: $2,475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,575 · Travel and Lodging: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,575.00 |
| Travel and Lodging | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,360.30 | 2019-2021 | |
| Medtronic, INC. | $3,287.50 | 2021-2023 | |
| Covidien LP | $1,013.00 | 2019 | |
| Stryker Corporation | $560.66 | 2019 | |
| Ethicon US, LLC | $410.89 | 2019-2021 | |
| Becton, Dickinson and Company | $373.33 | 2020 | |
| Conmed Corporation | $300.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $141.06 | 2020 | |
| Davol INC. | $121.63 | 2020-2022 | |
| Tetraphase Pharmaceuticals, INC. | $100.13 | 2019-2020 | |
| Organogenesis INC. | $77.37 | 2022 | |
| Braintree Laboratories, INC. | $48.88 | 2021 | |
| Shire North American Group INC | $31.76 | 2019 | |
| Integra Lifesciences Corporation | $22.38 | 2019 | |
| Teleflex LLC | $18.01 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $16.41 | 2020 | |
| Merck Sharp & Dohme LLC | $16.07 | 2019 | |
| Cook Medical LLC | $11.69 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lederman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.